Marketplace Donate Now Become a Member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Novotel Bucharest City Centre

Oct 22, 2019 8:00 AM - Oct 22, 2019 7:00 PM

Calea Victoriei 37B Sector 1, Bucharest, Romania, 010061

Clinical Trial Regulation Information Day for CEE Countries

Are Central and Eastern European Union member states ready to implement the new EU Clinical Trial Regulation (536/2014)? This information day provides a platform for discussion about the status of the implementation and further compliance with the new Regulation, as well as the associated legislation in the region.

Back to Agenda

Session 3: Procedure for Initial Authorization and Substantial Modifications

Session Chair(s)

Vladimir Vujovic, MPHARM

Vladimir Vujovic, MPHARM

Director, Clinical Trials Regulatory, IQVIA, Serbia

Procedure for Initial Authorization and Substantial Modifications

Speaker(s)

Stefan Strasser, MD

Stefan Strasser, MD

Head of Clinical Trials, Institute Surveillance, AGES, Austria

Massimiliano Sarra, PHD, MPH

Massimiliano Sarra, PHD, MPH

Permanent official and CTFG Secretary, Italian Medicine Agency (AIFA), Italy

Camelia Mihaescu

Camelia Mihaescu

GCP, GLP and PhV Inspections, European Medicines Agency, Netherlands

Have an account?